Victoza is a once-daily injection. At the start of treatment, your doctor will likely prescribe a daily dose of 0.6 mg. This starting dosage of Victoza helps reduce the risk of digestive side ...

GLP-1 agonists currently licensed for the treatment of obesity include a higher-dose version of Victoza called Saxenda (liraglutide) and a higher-dose version of Ozempic called Wegovy (semaglutide).

Novo Nordisk has settled a US patent case with Teva, which prevents the Israel-based generics firm marketing a cheaper version of its key type 2 diabetes drug Victoza until 2023.

Victoza offers a second option in these cases, he added. Victoza is Novo Nordisk’s once-daily injectable GLP-1 agonist and made around $3.6 billion in sales last year, making it the top-selling ...